|
|
Departments
Observations
A message from the editor of FDA Consumer.
Letters to the Editor
Topics: lawbreakers.
Updates
The latest information on FDA-related issues, gathered from
FDA Press Releases, Talk Papers, and other sources.
Research Notebook
Reports from public health and medical research.
fda.gov
Places of interest on FDA's Website and other government
and health-related sites.
Investigators' Reports
Selected cases illustrating regulatory and administrative
actions--such as inspections, recalls, seizures, and court
proceedings--by FDA's regional and district offices across
the country.
The Last Word
Commentary: Trans Fatty Acids: Better Decisions or Informatiion
Overload?
|
|
|
|
Features
HHS, FDA Implement Food
Security Research Program
The FDA steps up food security with a five-fold increase in inspections and a new research program.
MedWatch: Managing Risks at the FDA
How safety reports from the public make a difference.
Greater Access to Generic Drugs
Generic drugs are safe, effective, and cost less. The FDA has launched an initiative to encourage the availability of these alternatives to brand-name medications.
First Test Approved to Help Detect West
Nile Virus
What you need to know about the latest tool to help doctors combat West Nile virus.
Cover Story
Revealing Trans Fats
A new FDA rule requires that trans fats, which act like artery-clogging saturated fats, be included on food labels beginning in 2006.
Nasal Flu Vaccine Approved
A needle-free alternative arrives just in time for flu season.
Former FDA Press Officer Looks Back at
100
Centenarian Emil Corwin is a former FDA employee with a sound institutional memory.
Inside Clinical Trials: Testing Medical
Products in People
What are the risks and potential benefits involved in joining a clinical trial?
Daily Aspirin Therapy
Should you take aspirin to lower the risk of heart attack and stroke?
|
|
|
FDA Consumer is the official magazine of the U.S. Food and Drug Administration.
Text in the articles in FDA Consumer may
be republished without permission. Credit to FDA Consumer
as the source is appreciated.
|
|
|